Julia M Langton1, Bianca Blanch1, Anna K Drew2, Marion Haas3, Jane M Ingham4, Sallie-Anne Pearson5. 1. Faculty of Pharmacy, The University of Sydney, Sydney, NSW, Australia. 2. Prince of Wales Clinical School, Faculty of Medicine, The University of New South Wales, Sydney, NSW, Australia. 3. Centre for Health Economics Research and Evaluation, The University of Technology Sydney, Sydney, NSW, Australia. 4. Cunningham Centre for Palliative Care, Sacred Heart Health Service, NSW, Australia St Vincents' Hospital Clinical School, Faculty of Medicine, The University of New South Wales, NSW, Australia. 5. Faculty of Pharmacy, The University of Sydney, Sydney, NSW, Australia sallie.pearson@sydney.edu.au.
Abstract
BACKGROUND: There has been an increase in observational studies using health administrative data to examine the nature, quality, and costs of care at life's end, particularly in cancer care. AIM: To synthesize retrospective observational studies on resource utilization and/or costs at the end of life in cancer patients. We also examine the methods and outcomes of studies assessing the quality of end-of-life care. DESIGN: A systematic review according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and AMSTAR (A Measurement Tool to Assess Systematic Reviews) methodology. DATA SOURCES: We searched MEDLINE, Embase, CINAHL, and York Centre for Research and Dissemination (1990-2011). Independent reviewers screened abstracts of 14,424 articles, and 835 full-text manuscripts were further reviewed. Inclusion criteria were English-language; at least one resource utilization or cost outcome in adult cancer decedents with solid tumors; outcomes derived from health administrative data; and an exclusive end-of-life focus. RESULTS: We reviewed 78 studies examining end-of-life care in over 3.7 million cancer decedents; 33 were published since 2008. We observed exponential increases in service use and costs as death approached; hospital services being the main cost driver. Palliative services were relatively underutilized and associated with lower expenditures than hospital-based care. The 15 studies using quality indicators demonstrated that up to 38% of patients receive chemotherapy or life-sustaining treatments in the last month of life and up to 66% do not receive hospice/palliative services. CONCLUSION: Observational studies using health administrative data have the potential to drive evidence-based palliative care practice and policy. Further development of quality care markers will enhance benchmarking activities across health care jurisdictions, providers, and patient populations.
BACKGROUND: There has been an increase in observational studies using health administrative data to examine the nature, quality, and costs of care at life's end, particularly in cancer care. AIM: To synthesize retrospective observational studies on resource utilization and/or costs at the end of life in cancerpatients. We also examine the methods and outcomes of studies assessing the quality of end-of-life care. DESIGN: A systematic review according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and AMSTAR (A Measurement Tool to Assess Systematic Reviews) methodology. DATA SOURCES: We searched MEDLINE, Embase, CINAHL, and York Centre for Research and Dissemination (1990-2011). Independent reviewers screened abstracts of 14,424 articles, and 835 full-text manuscripts were further reviewed. Inclusion criteria were English-language; at least one resource utilization or cost outcome in adult cancer decedents with solid tumors; outcomes derived from health administrative data; and an exclusive end-of-life focus. RESULTS: We reviewed 78 studies examining end-of-life care in over 3.7 million cancer decedents; 33 were published since 2008. We observed exponential increases in service use and costs as death approached; hospital services being the main cost driver. Palliative services were relatively underutilized and associated with lower expenditures than hospital-based care. The 15 studies using quality indicators demonstrated that up to 38% of patients receive chemotherapy or life-sustaining treatments in the last month of life and up to 66% do not receive hospice/palliative services. CONCLUSION: Observational studies using health administrative data have the potential to drive evidence-based palliative care practice and policy. Further development of quality care markers will enhance benchmarking activities across health care jurisdictions, providers, and patient populations.
Authors: Emily M Ray; Richard F Riedel; Thomas W LeBlanc; Christel N Rushing; Anthony N Galanos Journal: J Palliat Med Date: 2018-11-03 Impact factor: 2.947
Authors: Jill M Steiner; James N Kirkpatrick; Susan R Heckbert; James Sibley; James A Fausto; Ruth A Engelberg; J Randall Curtis Journal: Congenit Heart Dis Date: 2018-09-19 Impact factor: 2.007
Authors: Stuart L Goldberg; Dhakshila Paramanathan; Raya Khoury; Sharmi Patel; Dayo Jagun; Srikesh Arunajadai; Victoria DeVincenzo; Ruth Pe Benito; Brooke Gruman; Sukhi Kaur; Scott Paddock; Andrew D Norden; Eric V Schultz; John Hervey; Terrill Jordan; Andre Goy; Andrew L Pecora Journal: Oncologist Date: 2018-09-28
Authors: Karen E Bremner; K Robin Yabroff; Diarmuid Coughlan; Ning Liu; Christopher Zeruto; Joan L Warren; Claire de Oliveira; Angela B Mariotto; Clara Lam; Michael J Barrett; Kelvin K-W Chan; Jeffrey S Hoch; Murray D Krahn Journal: JCO Oncol Pract Date: 2019-10-24
Authors: Yolanda W H Penders; Lieve Van den Block; Gé A Donker; Luc Deliens; Bregje Onwuteaka-Philipsen Journal: Br J Gen Pract Date: 2015-11 Impact factor: 5.386
Authors: Paul R Duberstein; Michael Chen; Michael Hoerger; Ronald M Epstein; Laura M Perry; Sule Yilmaz; Fahad Saeed; Supriya G Mohile; Sally A Norton Journal: J Pain Symptom Manage Date: 2019-10-19 Impact factor: 3.612